| Jailene Viviana Sotomayor Quijano, PHARMD | |
|
101 Calle Municipal, Arecibo, PR 00612-5712 | |
| (787) 201-6612 | |
| Not Available |
| Full Name | Jailene Viviana Sotomayor Quijano |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 101 Calle Municipal, Arecibo, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811586845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6676 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jailene Viviana Sotomayor Quijano, PHARMD 101 Calle Municipal, Arecibo, PR 00612-5712 Ph: () - | Jailene Viviana Sotomayor Quijano, PHARMD 101 Calle Municipal, Arecibo, PR 00612-5712 Ph: (787) 201-6612 |
News Archive
The Health Department in West Australia say there is a sharp increase in the mosquito-borne viral infection Dengue fever in people returning from Indonesia.
A protein found in cells throughout the body must be present in a specific set of neurons in the brain to prevent weight gain after chronic feeding on high-calorie meals, new findings from UT Southwestern Medical Center researchers suggest.
Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced enrollment initiation for a 120-patient, international pivotal clinical study to evaluate the safety and efficacy of the DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System designed to resorb in the body within 1 to 2 years after implantation and return the patients' coronary vessel to de novo state.
The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in the journal Open Forum Infectious Diseases.
Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant.
› Verified 1 days ago
Paula O. Lopez-rodriguez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: D9 Calle Helio Urb Los Aires, Arecibo, PR 00612 Phone: 787-689-0243 | |
Hilda Nieves, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: State Road 2 Km 802, Arecibo, PR 00612 Phone: 787-879-3696 Fax: 787-879-3666 | |
Judit Torres, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 259 Ave Juan Rosado, Arecibo, PR 00612 Phone: 787-878-3510 | |
Mrs. Luz G. Cruz, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: # 129 Victor Rojas Ii, Arecibo, PR 00612 Phone: 787-816-2156 Fax: 787-816-2156 | |
Dr. Yaritza Rios, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Calle 10 Interseccion 636, Bo La Planta, Arecibo, PR 00612 Phone: 787-817-0929 | |
Dr. Esther Marie Perez, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Carr. 682 Km 6.7, Bo. Garrrochales, Arecibo, PR 00612 Phone: 787-992-4400 Fax: 787-569-4400 | |
Mrs. Nimia I Vazquez, R.PH, MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: St. 129 Km 5.0 Bo. Hato Arriba, Arecibo, PR 00612 Phone: 787-878-6665 Fax: 787-878-6665 |